RAP1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.053600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.943800E-02
Normal-vs-Stage2
5.223600E-02
Normal-vs-Stage3
3.418000E-03
Normal-vs-Stage4
3.599200E-01
Stage1-vs-Stage2
4.237600E-01
Stage1-vs-Stage3
4.925200E-01
Stage1-vs-Stage4
1.802440E-01
Stage2-vs-Stage3
1.614010E-01
Stage2-vs-Stage4
2.765000E-01
Stage3-vs-Stage4
5.396300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.382100E-02
Normal-vs-AfricanAmerican
2.208000E-01
Normal-vs-Asian
4.867600E-02
Caucasian-vs-AfricanAmerican
4.336800E-01
Caucasian-vs-Asian
6.078000E-01
AfricanAmerican-vs-Asian
3.856600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.953900E-02
Normal-vs-Female
6.650000E-02
Male-vs-Female
2.077800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.172200E-02
Normal-vs-Age(41-60Yrs)
1.149050E-01
Normal-vs-Age(61-80Yrs)
2.915800E-02
Normal-vs-Age(81-100Yrs)
6.536800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.156800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.137600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.585200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.007940E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.010200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.236230E-02
Normal-vs-Daily Drinker
1.675860E-02
Normal-vs-Weekly Drinker
2.911500E-02
Normal-vs-Occasional Drinker
9.069900E-02
Normal-vs-Social Drinker
1.113240E-01
Non Drinker-vs-Daily Drinker
8.007200E-01
Non Drinker-vs-Weekly Drinker
7.958600E-01
Non Drinker-vs-Occasional Drinker
2.011800E-01
Non Drinker-vs-Social Drinker
4.724800E-01
Daily Drinker-vs-Weekly Drinker
9.689400E-01
Daily Drinker-vs-Occasional Drinker
1.739020E-01
Daily Drinker-vs-Social Drinker
4.061200E-01
Weekly Drinker-vs-Occasional Drinker
2.265200E-01
Weekly Drinker-vs-Social Drinker
4.577800E-01
Occasional Drinker-vs-Social Drinker
7.264000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.730000E-01
Normal-vs-Grade 2
8.205200E-01
Normal-vs-Grade 3
8.757200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.940000E-02
Grade 1-vs-Grade 3
1.907040E-01
Grade 1-vs-Grade 4
9.730000E-01
Grade 2-vs-Grade 3
2.277600E-01
Grade 2-vs-Grade 4
8.205200E-01
Grade 3-vs-Grade 4
8.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.006500E-02
Normal-vs-NonDiabetic
2.440300E-02
Diabetic-vs-NonDiabetic
7.863400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.291900E-02
Normal-vs-NoPancreatitis
2.821800E-02
Pancreatitis-vs-NoPancreatitis
9.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.511500E-02
Normal-vs-N1
4.779600E-02
N0-vs-N1
2.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.352300E-02
Normal-vs-TP53-NonMutant
3.999500E-02
TP53-Mutant-vs-TP53-NonMutant
2.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
